Dr. Rahul Gupta currently serves as the President of GATC Health, an AI-driven technology company focused on drug discovery, precision medicine and predictive analytics. From November 2021 to January 2025, Dr. Gupta served as the first medical doctor to lead the White House Office of National Drug Control Policy (ONDCP) as its Director. As the senior most drug policy advisor to the President of the United States, he coordinated the nation’s $44 billion drug budget across 19 federal agencies. Working at the intersection of national security, international diplomacy, economic policy and public health, Dr. Gupta is widely credited with achieving the most significant progress in the drug overdose crisis in American history. Previously, his passion for global health led him to join the March of Dimes as Chief Medical and Health Officer and Senior Vice President, where he provided strategic oversight for the organization’s domestic and global medical and public health efforts. Dr. Gupta has served as a local public health official and as the West Virginia Health Commissioner under two governors. His lifelong commitment to educating the next generation of physicians and policymakers has led him to hold academic appointments throughout his career including as a clinical professor in the Department of Medicine at Georgetown University School of Medicine and as visiting faculty at the Harvard University T.H. Chan School of Public Health. Dr. Gupta completed medical school at the University of Delhi followed by subspecialty training in pulmonary medicine. He earned a Master of Public Health from the University of Alabama Birmingham and a global Master of Business Administration in innovation and technology management from the London School of Business and Finance.